The World Health Organization authorized Abbott Laboratories' mpox diagnostic test for emergency use on Thursday, the first ...

MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in ...

Advancements and Projections in the Global Blood Sensor Market: Insights, Trends, Opportunities, and Recent DevelopmentsNew ...

We recently published a list of 10 Best Healthcare Stocks To Buy According to Hedge Funds. In this article, we are going to ...

In this article, we will be taking a look at the 7 best dialysis and kidney disease stocks to buy. Global Kidney Treatment ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Some people who use a Freestyle Libre 3 glucose sensor are facing delays getting their prescriptions filled. Abbott spokesperson Lindsy Delco said the delays are driven by strong demand for the Libre ...

Abbott ABT is facing a challenging business environment globally. Unfavorable foreign exchange impact continues to impede growth. The stock carries a Zacks Rank #4 (Sell) currently. A challenging ...

Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the ...

In the US, DexCom and Abbott Laboratories dominate the wearable ... and water-resistant up to 8ft for 24 hours. - Abbott Libre (Libre 2 and Libre 3) Very similar to G6/G7 but slightly better ...

Abbott Laboratories' diabetes care segment recently added new products to its lineup. It should remain one of the company's key growth drivers over the long run. There are other good reasons to ...

In June, Abbott Laboratories announced that the U.S. Food and Drug Administration (FDA) had cleared the Libre Rio, a new over-the-counter (OTC) CGM option for type 2 diabetes patients who do not ...